Medifast's three largest insider shareholders as of September 29, 2026 are Daniel R Chard (Chairman Ceo, 205.91K shares), Daniel R Chard (Chairman Ceo, 149.70K shares), James P. Maloney (Chief Financial Officer, 73.03K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Daniel R Chard | Chairman Ceo | 188,233 | 17,678 | 205,911 | 38.9% | 27 Mar, 2026 |
| 2 | James P. Maloney | Chief Financial Officer | 73,033 | 0 | 73,033 | 13.8% | 27 Mar, 2026 |
| 3 | Scott Schlackman | Director | 42,229 | 0 | 42,229 | 8.0% | 28 May, 2026 |
| 4 | Jeffrey J Brown | Director | 38,578 | 0 | 38,578 | 7.3% | 26 Jun, 2025 |
| 5 | Andrea B Thomas | Director | 35,697 | 0 | 35,697 | 6.7% | 28 May, 2026 |
| 6 | Elizabeth A. Geary | Director | 31,225 | 0 | 31,225 | 5.9% | 28 May, 2026 |
| 7 | Michael A. Hoer | Director | 26,139 | 0 | 26,139 | 4.9% | 26 Jun, 2025 |
| 8 | Jonathan Barrett Mackenzie | Vp, Finance Cao | 20,838 | 0 | 20,838 | 3.9% | 27 Mar, 2026 |
| 9 | Parsa Kiai | Director | 0 | 20,270 | 20,270 | 3.8% | 28 Aug, 2026 |
| 10 | Jeffrey Matthew Rose | Director | 18,419 | 0 | 18,419 | 3.5% | 28 May, 2026 |
| 11 | Kevin G Byrnes | Director | 14,922 | 0 | 14,922 | 2.8% | 15 Nov, 2021 |
| 12 | Constance J. Hallquist | Other | 0 | 2,152 | 2,152 | 0.4% | 30 Oct, 2023 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 26 Aug, 2026 | Parsa Kiai | Director | Acquired P | 41,975 | $12.26 | $514.75K | 707,492 | Indirect |
| 26 Aug, 2026 | Parsa Kiai | Director | Acquired P | 1,175 | $12.26 | $14.41K | 20,270 | Indirect |
| 24 Aug, 2026 | Parsa Kiai | Director | Acquired P | 4,211 | $12.00 | $50.53K | 665,517 | Indirect |
| 24 Aug, 2026 | Parsa Kiai | Director | Acquired P | 118 | $12.00 | $1.42K | 19,095 | Indirect |
| 19 Aug, 2026 | Parsa Kiai | Director | Acquired P | 28,538 | $11.66 | $332.68K | 619,331 | Indirect |
| 19 Aug, 2026 | Parsa Kiai | Director | Acquired P | 799 | $11.66 | $9.31K | 17,802 | Indirect |
| 20 Aug, 2026 | Parsa Kiai | Director | Acquired P | 41,975 | $11.60 | $487.07K | 661,306 | Indirect |
| 20 Aug, 2026 | Parsa Kiai | Director | Acquired P | 1,175 | $11.60 | $13.63K | 18,977 | Indirect |
| 26 May, 2026 | Andrea B Thomas | Director | Acquired A | 11,680 | $0.00 | $0 | 35,697 | Direct |
| 26 May, 2026 | Parsa Kiai | Director | Acquired A | 11,680 | $0.00 | $0 | 11,680 | Direct |
| 26 May, 2026 | Elizabeth A. Geary | Director | Acquired A | 11,680 | $0.00 | $0 | 31,225 | Direct |
| 26 May, 2026 | Ming Xian | Director | Acquired A | 11,680 | $0.00 | $0 | 43,823 | Direct |
| 26 May, 2026 | Scott Schlackman | Director | Acquired A | 11,680 | $0.00 | $0 | 42,229 | Direct |
| 26 May, 2026 | Jeffrey Matthew Rose | Director | Acquired A | 11,680 | $0.00 | $0 | 11,680 | Direct |
| 26 May, 2026 | Parsa Kiai | Director | Acquired A | 7,637 | $0.00 | $0 | 19,317 | Direct |
| 26 May, 2026 | Jeffrey Matthew Rose | Director | Acquired A | 6,739 | $0.00 | $0 | 18,419 | Direct |
| 08 May, 2026 | Scott Schlackman | Director | Acquired P | 2,500 | $12.65 | $31.63K | 28,049 | Direct |
| 11 May, 2026 | Scott Schlackman | Director | Acquired P | 2,500 | $12.53 | $31.33K | 30,549 | Direct |
| 13 Mar, 2026 | Jonathan Barrett Mackenzie | Vp, Finance Cao | Disposed F | 198 | $9.62 | $1.90K | 10,940 | Direct |
| 13 Mar, 2026 | James P. Maloney | Chief Financial Officer | Disposed F | 918 | $9.62 | $8.83K | 41,381 | Direct |